Tinzaparin
Showing 1 - 25 of 227
Epithelial Ovarian Cancer Trial in Sweden (Tinzaparin Injectable Solution)
Recruiting
- Epithelial Ovarian Cancer
- Tinzaparin Injectable Solution
-
Eksjö, Sweden
- +5 more
Sep 28, 2022
Severe COVID-19 Pneumonia Trial in Créteil (Tinzaparin, Low dose prophylactic anticoagulation, Tinzaparin, High dose
Completed
- Severe COVID-19 Pneumonia
- Tinzaparin, Low dose prophylactic anticoagulation
- +2 more
-
Créteil, FranceHenri Mondor Hospital
Sep 5, 2022
Deep Vein Thrombosis, Post Thrombotic Syndrome Trial in Hamilton, Toronto (tinzaparin, Rivaroxaban)
Recruiting
- Deep Vein Thrombosis
- Post Thrombotic Syndrome
- tinzaparin
- Rivaroxaban
-
Hamilton, Ontario, Canada
- +2 more
May 4, 2022
Anticoagulant, Venous Thromboembolism, Prophylaxis Trial in Denmark (Dalteparin Prefilled Syringe, Tinzaparin profiled syringe)
Recruiting
- Anticoagulant
- +3 more
- Dalteparin Prefilled Syringe
- Tinzaparin profiled syringe
-
Copenhagen, Denmark
- +8 more
Aug 29, 2023
Pancreatic Cancer, Thromboembolism Trial in Athens (Innohep, Chemotherapy: Gemcitabine + Nab-Paclitaxel)
Recruiting
- Pancreatic Cancer
- Thromboembolism
- Innohep
- Chemotherapy: Gemcitabine + Nab-Paclitaxel
-
Athens, Attiki, Greece
- +1 more
Mar 28, 2022
Venous Thromboembolism, Varicose Veins Trial in London (Dalteparin Sodium, Tinzaparin Sodium, Enoxaparin Sodium)
Not yet recruiting
- Venous Thromboembolism
- Varicose Veins
- Dalteparin Sodium
- +5 more
-
London, United KingdomImperial College Hospital NHS Foundation Trust
Feb 20, 2023
Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients
Recruiting
- Covid19
- Hospitalization
- tinzaparin
-
Patras, Achaia, Greece
- +6 more
Sep 6, 2021
Colorectal Cancer Metastatic, Thromboembolism Trial in Spain (Tinzaparin)
Not yet recruiting
- Colorectal Cancer Metastatic
- Thromboembolism
- Tinzaparin
-
Santiago De Compostela, A Coruña, Spain
- +32 more
Nov 23, 2022
Cancer-associated Thrombosis, Thrombocytopenia Trial (Enoxaparin, Dalteparin, Tinzaparin)
Not yet recruiting
- Cancer-associated Thrombosis
- Thrombocytopenia
- Enoxaparin
- +2 more
- (no location specified)
Apr 19, 2022
Pancreas Cancer, Pancreas Tumor, Surgery Trial (enoxaparin/tinzaparin/dalteparin)
Not yet recruiting
- Pancreas Cancer
- +4 more
- (no location specified)
Feb 8, 2022
Liver Cancer, Surgery, Thrombosis, Deep Vein Trial in Finland, Norway (enoxaparin or tinzaparin or dalteparin, No intervention)
Recruiting
- Liver Cancer
- +4 more
- enoxaparin or tinzaparin or dalteparin
- No intervention
-
Helsinki, Finland
- +5 more
Sep 21, 2022
Deep Vein Thrombosis, Inflammatory Response Trial in Amiens (Tinzaparin)
Recruiting
- Deep Vein Thrombosis
- Inflammatory Response
- Tinzaparin
-
Amiens, FranceCHU Amiens
Feb 2, 2021
Covid19, Thrombosis Trial in Spain (Tinzaparin)
Completed
- Covid19
- Thrombosis
- Tinzaparin
-
A Coruña, Spain
- +17 more
Sep 13, 2022
Adenocarcinoma of the Colon Trial in Belgium, Canada, France (Tinzaparin)
Completed
- Adenocarcinoma of the Colon
- Tinzaparin
-
Ghent, Belgium
- +15 more
May 14, 2021
Deep Venous Thrombosis, Pulmonary Embolism Trial in Worldwide (Low dose nadroparin, Intermediate dose nadroparin, Low dose
Completed
- Deep Venous Thrombosis
- Pulmonary Embolism
- Low dose nadroparin
- +7 more
-
New York, New York
- +71 more
May 21, 2022
Venous Thromboembolism, Lung Tumor Trial in France (Tinzaparin Sodium)
Terminated
- Venous Thromboembolism
- Lung Neoplasm
- Tinzaparin Sodium
-
Rennes, Bretagne, France
- +26 more
Nov 14, 2022
Dosing of Thromboprophylaxis and Mortality in Critically Ill
Completed
- Covid19
- Thromboembolism
- Dose of tinzaparin or dalteparin
-
Stockholm, SwedenSödersjukhuset
Oct 18, 2020
28-days Mortality in Critically Ill COVID-19 Patients
Completed
- Covid-19
- +2 more
- Dose of Tinzaparin or Dalteparin
-
Stockholm, Stockholms Län, SwedenSouth General Hospital
Jun 18, 2020
COVID19 Pneumonia Trial in Colombes, Paris (Tinzaparin or unfractionated heparin)
Unknown status
- COVID19 Pneumonia
- Tinzaparin or unfractionated heparin
-
Colombes, Hauts De Seine, France
- +2 more
Apr 14, 2020
Validation of Ottawa Score in Cancer Venous Thromboembolism
Completed
- Venous Thromboembolism
- Tinzaparin
-
Paris, FranceGeorge Pompidou European Hospital
Dec 13, 2019
Antiphospholipid Syndrome in Pregnancy, Pregnancy Loss Trial in Ottawa (Aspirin 81 mg, Low-molecular-weight heparin)
Terminated
- Antiphospholipid Syndrome in Pregnancy
- Pregnancy Loss
- Aspirin 81 mg
- Low-molecular-weight heparin
-
Ottawa, Ontario, CanadaOttawa Hospital Research Institute
Mar 25, 2020
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022
Venous Thromboembolism Trial in Toronto (Prophylactic low molecular weight heparin, Low molecular weight heparin and low-dose
Recruiting
- Venous Thromboembolism
- Prophylactic low molecular weight heparin
- Low molecular weight heparin and low-dose aspirin
-
Toronto, Ontario, CanadaMount Sinai Hospital
Jan 18, 2023
Hepatic Disease, Surgery-Complications, Hypercoagulability Trial in London (Redesca (enoxaparin sodium for injection), Fragmin
Not yet recruiting
- Hepatic Disease
- +3 more
- Redesca (enoxaparin sodium for injection)
- Fragmin (dalteparin)
-
London, Ontario, CanadaLondon Health Sciences Centre
Nov 22, 2023